Literature DB >> 1675806

Multidrug resistance gene family and chemical carcinogens.

S S Thorgeirsson1, J A Silverman, T W Gant, P A Marino.   

Abstract

The data discussed in this review indicate that the coordinated induction of both the mdr gene family and a subfamily of the cytochrome P-450 supergene family provide a unified response of the organism to prevent lethal accumulation of xenobiotics. Consequently, a distinct physiological role for the mdr multigene family now exists. Furthermore, recent evidence suggests the existence of multiple receptors with overlapping substrate specificity that are involved in the induction of both mdr and P-4501A gene families. The increased expression of mdr gene(s) in the early stages of liver carcinogenesis and presumably in other tissues is associated with the development of xenobiotic resistance that is observed in the preneoplastic cell populations. These observations may have important clinical implications and may provide an explanation for resistance to chemotherapy of tumors in organs such as liver and colon that are frequently exposed to both environmental and dietary xenobiotics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675806     DOI: 10.1016/0163-7258(91)90059-u

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  10 in total

1.  Characterization of the rat mdr2 promoter and its regulation by the transcription factor Sp1.

Authors:  P C Brown; J A Silverman
Journal:  Nucleic Acids Res       Date:  1996-08-15       Impact factor: 16.971

2.  Differential effects of mitomycin C and doxorubicin on P-glycoprotein expression.

Authors:  R Maitra; P A Halpin; K H Karlson; R L Page; D Y Paik; M O Leavitt; B D Moyer; B A Stanton; J W Hamilton
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

3.  Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS).

Authors:  J M Dintaman; J A Silverman
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

4.  Expression of the Stem Cell Marker ABCB5 in Normal and Tumor Tissues.

Authors:  Mohamed E M Saeed; Joelle C Boulos; Kevin Machel; Nasim Andabili; Thamail Marouni; Wilfried Roth; Thomas Efferth
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

5.  Cloning and regulation of the rat mdr2 gene.

Authors:  P C Brown; S S Thorgeirsson; J A Silverman
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

Review 6.  Pharmacokinetic optimisation of treatment with oral etoposide.

Authors:  Giuseppe Toffoli; Giuseppe Corona; Barbara Basso; Mauro Boiocchi
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  Is the testis a chemo-privileged site? Is there a blood-testis barrier?

Authors:  Dhiren S Dave; John T Leppert; Jacob Rajfer
Journal:  Rev Urol       Date:  2007

8.  Evaluation of the P-glycoprotein (Abcb1) affinity status of a series of morphine analogs: comparative study with meperidine analogs to identify opioids with minimal P-glycoprotein interactions.

Authors:  Hazem E Hassan; Susan L Mercer; Christopher W Cunningham; Andrew Coop; Natalie D Eddington
Journal:  Int J Pharm       Date:  2009-04-05       Impact factor: 5.875

9.  MDR1 causes resistance to the antitumour drug miltefosine.

Authors:  M Rybczynska; R Liu; P Lu; F J Sharom; E Steinfels; A D Pietro; M Spitaler; H Grunicke; J Hofmann
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

10.  Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440).

Authors:  J Hofmann; I Utz; M Spitaler; S Hofer; M Rybczynska; W T Beck; D B Herrmann; H Grunicke
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.